Main > ONCOLOGY (**) > Lung>NSCLC>EGFR+>MET>*** > Treatment > Co: USA. A. Erlotinib.HCl Tablets *
Co: USA. A. Erlotinib.HCl Tablets *'s subsections
(*) EU Approval Date: 2005. 09.
(*) USA Approval Date: 2004. 11
>with Exon 19 Deletions or Exon 21>
Companion Diagnostics>
Company
Marketing in EU By:
Marketing in USA By:
Patent>Assignee; Claims; No.; Etc.
TradeMark
TradeMark Web-Site (USA)
Co: USA. A. Erlotinib.HCl Tablets *'s products
This section has no products